Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Angela R. Smith, MD, MS, Erica D. Warlick, MD, Rachel K. Fonstad, M.S., Michelle A. Roesler, Jenny N. Poynter, PhD, Betsy Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Julie A Ross, PhD

Blood (2013) 122 (21): 1541.

https://doi.org/10.1182/blood.V122.21.1541.1541

Published: 2013

Journal Articles

Disease Characteristics and Prognostic Implications Of Cell Surface FLT3 Receptor (CD135) Expression In Pediatric Acute Myeloid Leukemia – A Report From Children’s Oncology Group

Katherine Tarlock, MD, Todd A. Alonzo, PhD, Michael R. Loken, PhD, Robert B. Gerbing, MA, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Susana C. Raimondi, PhD, Betsy Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 2609.

https://doi.org/10.1182/blood.V122.21.2609.2609

Published: 2013

Journal Articles

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Daniel Pease, MD, Julie A Ross, PhD, Phuong L. Nguyen, MD, Betsy Hirsch, PhD, Adina Cioc, MD, Angela R. Smith, MD, MS, Michelle A. Roesler, Rachel K. Fonstad, M.S., Erica D. Warlick, MD

Blood (2013) 122 (21): 2798.

https://doi.org/10.1182/blood.V122.21.2798.2798

Published: 2013

Journal Articles

Negative Prognostic Impact Of High CD33 Expression Is Negated With The Use Of Gemtuzumab Ozogamicin: A Report From The Children’s Oncology Group

Jessica Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Susana C Raimondi, PhD, Betsy Hirsch, PhD, Richard Aplenc, MD, Alan S. Gamis, MD, MPH, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 491.

https://doi.org/10.1182/blood.V122.21.491.491

Published: 2013

Journal Articles

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Betsy Hirsch, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Samir Kahwash, MD, Amy Heerema-McKenney, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Laura Winter, PharmD, Kathleen Glick, CCRP, Stella M. Davies, MBBS, PhD, Patti Byron, MSN, RN, Robert S. Lavey, MD, Franklin O. Smith, MD, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD

Blood (2013) 122 (21): 612.

https://doi.org/10.1182/blood.V122.21.612.612

Published: 2013

Journal Articles

Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531

Alan S. Gamis, MD, MPH, Richard Aplenc, MD, PhD, Todd A. Alonzo, PhD, Lillian Sung, MD, PhD, Soheil Meshinchi, MD, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Stella M. Davies, MBBS, PhD, Patti Byron, MSN, RN, Franklin O. Smith, MD

Blood (2013) 122 (21): 355.

https://doi.org/10.1182/blood.V122.21.355.355

Published: 2013

Journal Articles

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Erica D. Warlick, MD, Phuong L. Nguyen, MD, Rachel K. Fonstad, M.S., Adina Cioc, MD, Betsy Hirsch, PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Michelle A. Roesler, Julie A Ross, PhD

Blood (2013) 122 (21): 1546.

https://doi.org/10.1182/blood.V122.21.1546.1546

Published: 2013

Journal Articles

Myelodysplastic Syndrome in Fanconi Anemia: Morphologic and Cytogenetic Findings Are Strongly Correlated.

Adina M. Cioc, MD, John E. Wagner, MD, Margaret L. MacMillan, MD, Betsy Hirsch, PhD

Blood (2007) 110 (11): 2458.

https://doi.org/10.1182/blood.V110.11.2458.2458

Published: 2007

Journal Articles

Genetic Influence on the Systems Biology of Sickle Stroke Risk Detected by Endothelial Gene Expression.

Robert P. Hebbel, MD, Peng Wei, MS, Aixiang Jiang, MS, Cheryl Hillery, MD, J. Paul Scott, MD, Stephen C. Nelson, MD, Judy Enenstein, PhD, Liming Milbauer, PhD, Vidya Bodempudi, Wei Pan, PhD, Betsy Hirsch, PhD, James N. Topper, MD, PhD, Ruey-Bing Yang, PhD

Blood (2007) 110 (11): 427.

https://doi.org/10.1182/blood.V110.11.427.427

Published: 2007

NARROW

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Disease Characteristics and Prognostic Implications Of Cell Surface FLT3 Receptor (CD135) Expression In Pediatric Acute Myeloid Leukemia – A Report From Children’s Oncology Group

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Negative Prognostic Impact Of High CD33 Expression Is Negated With The Use Of Gemtuzumab Ozogamicin: A Report From The Children’s Oncology Group

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome in Fanconi Anemia: Morphologic and Cytogenetic Findings Are Strongly Correlated.

Genetic Influence on the Systems Biology of Sickle Stroke Risk Detected by Endothelial Gene Expression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only